Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
The Latest on: Cancer Therapeutics
via Google News
The Latest on: Cancer Therapeutics
- TG Therapeutics downgraded at BofA with a bearish view on blood cancer candidateon May 20, 2022 at 9:40 am
The commercial-stage biotech, TG Therapeutics (TGTX) is trading lower for the third straight session on Friday after Bank of America downgraded the company citing the commercial ...
- Global Head and Neck Cancer Therapeutics Market Report 2022: Historical Data 2017-2020, Base year of 2021, Estimates for 2022, & Forecasts 2023-2027on May 20, 2022 at 1:53 am
The Global Head and Neck Cancer Therapeutics Market value in the year 2021 was USD2024.33 million that is expected to further grow with ...
- Sirnaomics will present clinical study results and development strategy for Cancer RNA Therapeutics at the 2022 Pre-ASCO China Summiton May 19, 2022 at 9:20 pm
GAITHERSBURG, Md. and SUZHOU, China, May 20, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development ...
- Europe Breast Cancer Therapeutics Market Size, Analysis, Competitive Strategies and Forecasts to 2028on May 18, 2022 at 7:43 am
According to the market analysis report titled 'Europe Breast Cancer Therapeutics Market Forecast 2028 By Therapy, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic ...
- Differentiated Thyroid Cancer Therapeutics Market One the Most Booming Industry in Upcoming Years Due to Global Demand in Industry by 2027on May 18, 2022 at 5:49 am
According to WHO thyroid cancer therapeutics, differentiated thyroid cancer is divided into papillary and follicular thyroid cancer. These cancer types are called as differentiated cancer since ...
- Novateur Ventures Participates in Founding and Financing of Epitopea, a New Cancer Therapeutics Companyon May 18, 2022 at 5:47 am
Novateur Ventures, a leading global life sciences advisory firm, announced it has participated in the $13.6M (£10.3M) seed investment raised by Epitopea, a cancer therapeutics company recently spun ...
- Liver Cancer Therapeutics Market Scope 2022: Driving Factors, Market Analysis, Investment Feasibility and Trends Forecast To 2028on May 18, 2022 at 1:14 am
Liver Cancer Therapeutics Market" research report 2022 provides size estimates, average price by manufacturers, ...
- Global Head and Neck Cancer Therapeutics Market Report 2022: Diagnostic Methods v/s Treatment Type - Forecast to 2027 - ResearchAndMarkets.comon May 17, 2022 at 9:19 am
DUBLIN, May 17, 2022--(BUSINESS WIRE)--The "Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods v/s Treatment Type), By Treatment Type (By Disease Indication, By Route of ...
- Sorrento Therapeutics shares are trading high following FDA clearance of IND for Abivertinib in metastatic castrate resistant prostate cancer (mCRPC)on May 17, 2022 at 7:34 am
Sorrento Therapeutics, Inc. (NASDAQ: SRNE) received clearance from the U.S. Food and Drug Administration (FDA) for its investigational new drug application (IND) of Abivertinib (Fujovee) for patients ...
- How fat could help in tailoring cancer treatment planson May 16, 2022 at 8:09 am
Osaka, Japan – In recent years, the immunotherapy field has revolutionized oncology treatment methods by developing therapeutics that help a cancer patient’s own immune system fight their disease.
via Bing News